UBS AM’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$119M Buy
426,038
+30,961
+8% +$8.92M 0.02% 477
2025
Q4
$120M Sell
395,077
-2,094
-0.5% -$653K 0.03% 454
2025
Q3
$111M Buy
397,171
+380,422
+2,271% +$104M 0.02% 455
2025
Q2
$4.04M Sell
16,749
-366,058
-96% -$86.5M ﹤0.01% 1810
2025
Q1
$93.2M Sell
382,807
-5,820
-1% -$1.75M 0.02% 558
2024
Q4
$128M Sell
388,627
-52,471
-12% -$17.8M 0.03% 466
2024
Q3
$148M Buy
441,098
+4,260
+1% +$1.35M 0.04% 418
2024
Q2
$119M Buy
436,838
+14,681
+3% +$4.27M 0.03% 418
2024
Q1
$146M Sell
422,157
-81,051
-16% -$26.7M 0.05% 348
2023
Q4
$162M Sell
503,208
-71,322
-12% -$22.4M 0.06% 310
2023
Q3
$206M Buy
574,530
+40,239
+8% +$15.5M 0.09% 228
2023
Q2
$256M Hold
534,291
0.12% 175
2023
Q1
$256M Buy
534,291
+114,866
+27% +$53.8M 0.12% 175
2022
Q4
$176M Buy
419,425
+25,392
+6% +$10.2M 0.09% 245
2022
Q3
$164M Buy
394,033
+19,245
+5% +$9.59M 0.09% 240
2022
Q2
$186M Buy
374,788
+28,416
+8% +$14.8M 0.1% 224
2022
Q1
$195M Buy
346,372
+2,495
+0.7% +$1.5M 0.08% 259
2021
Q4
$260M Sell
343,877
-13,723
-4% -$10.3M 0.1% 217
2021
Q3
$267M Sell
357,600
-12,576
-3% -$9.42M 0.11% 191
2021
Q2
$239M Sell
370,176
-12,624
-3% -$7.68M 0.1% 214
2021
Q1
$219M Sell
382,800
-120,757
-24% -$71.5M 0.1% 223
2020
Q4
$294M Buy
503,557
+117,413
+30% +$66.9M 0.14% 146
2020
Q3
$199M Sell
386,144
-26,428
-6% -$13.4M 0.11% 176
2020
Q2
$186M Buy
412,572
+46,288
+13% +$20.4M 0.11% 177
2020
Q1
$128M Sell
366,284
-75,058
-17% -$27.6M 0.09% 220
2019
Q4
$163M Buy
441,342
+22,837
+5% +$8.05M 0.1% 219
2019
Q3
$139M Buy
418,505
+21,281
+5% +$6.94M 0.09% 228
2019
Q2
$124M Buy
397,224
+10,536
+3% +$3.15M 0.09% 249
2019
Q1
$118M Sell
386,688
-28,125
-7% -$7.59M 0.09% 249
2018
Q4
$96.3M Buy
414,813
+160,075
+63% +$42.9M 0.08% 263
2018
Q3
$79.7M Sell
254,738
-19,441
-7% -$6.03M 0.06% 335
2018
Q2
$79.1M Sell
274,179
-6,296
-2% -$1.74M 0.06% 350
2018
Q1
$70.1M Sell
280,475
-78,936
-22% -$20.1M 0.06% 372
2017
Q4
$85.8M Sell
359,411
-51,887
-13% -$12.6M 0.07% 300
2017
Q3
$91.4M Sell
411,298
-15,829
-4% -$3.56M 0.08% 266
2017
Q2
$96.7M Sell
427,127
-9,706
-2% -$2.12M 0.09% 252
2017
Q1
$87.1M Sell
436,833
-29,952
-6% -$5.77M 0.09% 254
2016
Q4
$85.1M Buy
466,785
+38,714
+9% +$6.6M 0.1% 232
2016
Q3
$70.1M Sell
428,071
-20,763
-5% -$3.15M 0.08% 281
2016
Q2
$64.2M Buy
448,834
+33,077
+8% +$4.72M 0.07% 294
2016
Q1
$56.8M Sell
415,757
-55,093
-12% -$7.23M 0.07% 322
2015
Q4
$65.3M Sell
470,850
-105,749
-18% -$14.7M 0.07% 286
2015
Q3
$77.4M Sell
576,599
-13,322
-2% -$1.92M 0.09% 266
2015
Q2
$88.8M Buy
589,921
+36,118
+7% +$5.17M 0.09% 254
2015
Q1
$74.9M Sell
553,803
-8,636
-2% -$1.07M 0.07% 295
2014
Q4
$67.8M Sell
562,439
-6,156
-1% -$709K 0.06% 320
2014
Q3
$64.5M Sell
568,595
-17,180
-3% -$2.04M 0.06% 324
2014
Q2
$70.1M Sell
585,775
-12,096
-2% -$1.48M 0.07% 301
2014
Q1
$76.6M Sell
597,871
-36,526
-6% -$4.68M 0.08% 274
2013
Q4
$78.4M Buy
634,397
+69,735
+12% +$8.5M 0.09% 249
2013
Q3
$66.4M Sell
564,662
-27,200
-5% -$3.21M 0.08% 272
2013
Q2
$66.4M Buy
+591,862
New +$69.4M 0.09% 258

Other funds holding BIO